Medication: from the molecule to the patient

Strasbourg is a cutting edge university for health, as evidenced by its four Nobel Prizes in the field and its numerous ‘excellence’ labels awarded by the French government.

Thanks to the Medalis Drug Research Centre, the University supports excellence in research and capitalises on the findings to help make a direct impact on the patient. Over six years, five start-ups have been created and are still active today, and 12 licensed patents have been filed. Medalis, a genuine success story!

The Drug Research Centre aims to develop innovative medication for treating cancer and inflammation by launching high-stakes projects leading to the creation of potential start-ups.

We want to stimulate creativity and innovation and let new ideas prosper!” explains its director, Sylviane Muller, who wants to see competitive basic scientific research while letting society benefit from the concrete consequences of these innovations.

Sylviane Muller is a renowned scientist who, amongst other things, discovered and patented a molecule capable of correcting the immune deficiencies of the autoimmune disease systemic lupus erythematosus, for which there is currently no specific treatment. She was awarded the CNRS Innovation Medal 2015, a prestigious distinction reserved for exceptional research leading to innovations that have a huge impact on technological, therapeutic and societal levels.

h

Ces six dernières années, cinq start-ups sont nées de Medalis et toujours en activité : elles dynamisent le tissu économique local en créant de la richesse et de l’emploi. Aujourd’hui, nous souhaitons accélérer la maturation des projets grâce à un fonds qui offrira davantage de moyens aux projets de recherche à fort potentiel pour que des recherches au stade pré-clinique soient transférées à la start-up.

En soutenant l’une des meilleures universités d’Europe en santé et des chercheurs exceptionnels aux résultats prouvés, vous encouragez la recherche scientifique publique et ses retombées directes pour les patients.


 

Pour plus d’informations, n’hésitez pas à contacter Claire Ditner au 03.68.85.51.19
ou par email : ditner@icfrc.fr    

RETOUR